{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:57:37Z","timestamp":1770350257418,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12020-017-1468-1","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T08:47:30Z","timestamp":1510735650000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Oxidative stress in adult growth hormone deficiency: different plasma antioxidant patterns in comparison with metabolic syndrome"],"prefix":"10.1007","volume":"59","author":[{"given":"Antonio","family":"Mancini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Di Segni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Guidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Silvestrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Meucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Tiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,15]]},"reference":[{"key":"1468_CR1","doi-asserted-by":"publisher","unstructured":"A. Colao, P. Marzullo, C. Di Somma, G. Lombardi, Growth hormone and the heart. Clin. Endocrinol. (2001). \n                        https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01218.x","DOI":"10.1046\/j.1365-2265.2001.01218.x"},{"key":"1468_CR2","first-page":"173","volume":"1","author":"SA Beshyah","year":"1994","unstructured":"S.A. Beshyah, A. Henderson, R. Niththyanathan, P. Sharp, W. Richmond, D.G. Johnston, Metabolic abnormalities in growth hormone deficient adults: carbohydrate tolerance and lipid metabolism. Endocrinol. Metab. 1, 173\u2013180 (1994)","journal-title":"Endocrinol. Metab."},{"key":"1468_CR3","doi-asserted-by":"publisher","unstructured":"T.A.M. Abdu, R. Neary, T.A. Elhadd, M. Akber, R.N. Clayton, Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities. Clin. Endocrinol. (2001). \n                        https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01320.x","DOI":"10.1046\/j.1365-2265.2001.01320.x"},{"key":"1468_CR4","doi-asserted-by":"publisher","unstructured":"S.A. Beshyah, C. Freemantle, E. Thomas, B. Page, M. Murphy, D.G. Johnston, Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin. Endocrinol. (1995). \n                        https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb01860.x","DOI":"10.1111\/j.1365-2265.1995.tb01860.x"},{"key":"1468_CR5","doi-asserted-by":"publisher","unstructured":"L. L\u00f6nn, G. Johansson, L. Sj\u00f6str\u00f6m, H. Kvist, A. Od\u00e9n, B. Bengtsson, Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment. Obes. Res. (1996). \n                        https:\/\/doi.org\/10.1002\/j.1550-8528.1996.tb00511.x","DOI":"10.1002\/j.1550-8528.1996.tb00511.x"},{"key":"1468_CR6","doi-asserted-by":"publisher","unstructured":"J.O. J\u00f8rgensen, S.A. Pedersen, L. Thuesen, J. J\u00f8rgensen, T. Ingemann-Hansen, N.E. Skakkebaek, J.S. Christiansen, Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989). \n                        https:\/\/doi.org\/10.1016\/S0140-6736(89)92328-3","DOI":"10.1016\/S0140-6736(89)92328-3"},{"key":"1468_CR7","unstructured":"S.M. Libber, L.P. Plotnick, A.J. Johanson, R.M. Blizzard, P.O. Kwiterovich, C.J. Migeon, Long-term follow-up of hypopituitary patients treated with human growth hormone. Medicine (1990). https:\/\/doi.org\/0025-7974\/90\/0046-0055$02.00\/0"},{"key":"1468_CR8","doi-asserted-by":"publisher","unstructured":"J.O. Johansson, K. Landin, L. Tengborn, T. Rosen, B.A. Bengtsson, High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arter. Thromb. (1994). \n                        https:\/\/doi.org\/10.1161\/01.ATV.14.3.434","DOI":"10.1161\/01.ATV.14.3.434"},{"key":"1468_CR9","doi-asserted-by":"publisher","unstructured":"C.R. Palmiero, I.K. Anand R. Dardi, N. Balasubramaniyam, M.D. Schwarcz, I.A. Weiss, Growth hormone and the cardiovascular system. Cardiol. Rev. (2012). \n                        https:\/\/doi.org\/10.1097\/CRD.0b013e318248a3e1","DOI":"10.1097\/CRD.0b013e318248a3e1"},{"key":"1468_CR10","doi-asserted-by":"publisher","unstructured":"J. Verhelst, R. Abs, Cardiovascular risk factors in hypopituitary GH-deficient adults. Eur. J. Endocrinol. (2009). \n                        https:\/\/doi.org\/10.1530\/EJE-09-0291","DOI":"10.1530\/EJE-09-0291"},{"key":"1468_CR11","doi-asserted-by":"publisher","unstructured":"M. Leonsson, J. Hulthe, G. Johannsson, O. Wiklund, J. Wikstrand, B.A. Bengtsson, J. Oscarsson, Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness. Clin. Endocrinol. (2003). \n                        https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01832.x","DOI":"10.1046\/j.1365-2265.2003.01832.x"},{"key":"1468_CR12","doi-asserted-by":"publisher","unstructured":"R. P\u00e9rez, M. Garc\u00eda-Fern\u00e1ndez, M. D\u00edaz-S\u00e1nchez, J.E. Puche, G. Delgado, M. Conchillo, J. Muntan\u00e9, I. Castilla-Cort\u00e1zar, Mitochondrial protection by low doses of insulin-like growth factor-I in experimental cirrhosis. World J. Gastroenterol. (2008). \n                        https:\/\/doi.org\/10.3748\/wjg.14.2731","DOI":"10.3748\/wjg.14.2731"},{"key":"1468_CR13","doi-asserted-by":"publisher","unstructured":"J.E. Puche, M. Garc\u00eda-Fern\u00e1ndez, J. Muntan\u00e9, J. Rioja, S. Gonz\u00e1lez-Bar\u00f3n, I. Castilla-Cort\u00e1zar, Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats. Endocrinology (2008). \n                        https:\/\/doi.org\/10.1210\/en.2007-1563","DOI":"10.1210\/en.2007-1563"},{"key":"1468_CR14","doi-asserted-by":"publisher","unstructured":"M. Garc\u00eda-Fern\u00e1ndez, G. Delgado, J.E. Puche, S. Gonz\u00e1lez-Bar\u00f3n, I.C. Cort\u00e1zar, Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. Endocrinology (2008). \n                        https:\/\/doi.org\/10.1210\/en.2007-1190","DOI":"10.1210\/en.2007-1190"},{"key":"1468_CR15","doi-asserted-by":"publisher","unstructured":"A. Mancini, R. Festa, V. Di Donna, E. Leone, G.P. Littarru, A. Silvestrini, E. Meucci, A. Pontecorvi, Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes. J. Endocrinol. Invest. (2010). \n                        https:\/\/doi.org\/10.1007\/BF03346615","DOI":"10.1007\/BF03346615"},{"key":"1468_CR16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1139\/z96-070","volume":"74","author":"CD Rollo","year":"1996","unstructured":"C.D. Rollo, J. Carlson, M. Sawada, Accelerated aging of giant transgenic mice is associated with elevated free radicals process. Can. J. Zool. 74, 606\u2013620 (1996)","journal-title":"Can. J. Zool."},{"key":"1468_CR17","doi-asserted-by":"publisher","unstructured":"H.M. Brown-Borg, A.M. Bode, A. Bartke, Antioxidative mechanism and plasma growth hormone levels: potential relationship in the aging process. Endocrinology (1999). \n                        https:\/\/doi.org\/10.1385\/ENDO:11:1:41","DOI":"10.1385\/ENDO:11:1:41"},{"key":"1468_CR18","doi-asserted-by":"publisher","unstructured":"A. Mancini, G.E. Martorana, M. Magini, R. Festa, S. Raimondo, A. Silvestrini, N. Nicolotti, A. Mordente, M.C. Mele, G.A.D. Miggiano, E. Meucci, Oxidative stress and metabolic syndrome: effects of a antioxidants enriched diet on insulin resistance. Clin. Nutr. (2015). \n                        https:\/\/doi.org\/10.1016\/j.clnesp.2014.11.002","DOI":"10.1016\/j.clnesp.2014.11.002"},{"key":"1468_CR19","doi-asserted-by":"publisher","unstructured":"G.A. Aguirre, J.R. De Ita, R.G. de la Garza, I. Castilla-Cortazar, Insulin-like growth factor-1 deficiency and metabolic syndrome. J. Transl. Med. (2016). \n                        https:\/\/doi.org\/10.1186\/s12967-015-0762-z","DOI":"10.1186\/s12967-015-0762-z"},{"key":"1468_CR20","doi-asserted-by":"publisher","unstructured":"C. Rice-Evans, N.J. Miller, Total antioxidant status in plasma and body fluids. Methods Enzymol. (1994). \n                        https:\/\/doi.org\/10.1016\/0076-6879(94)34095-1","DOI":"10.1016\/0076-6879(94)34095-1"},{"key":"1468_CR21","volume-title":"Energy and Defence","author":"GP Littarru","year":"1994","unstructured":"G.P. Littarru, Energy and Defence (CESI, Roma1994)"},{"key":"1468_CR22","doi-asserted-by":"publisher","unstructured":"A. Giustina, W. B. Weherenberg, Influence of thyroid hormones on the regulation of growth hormone secretion. Eur. J. Endocrinol. (1995). \n                        https:\/\/doi.org\/10.1530\/eje.0.1330646","DOI":"10.1530\/eje.0.1330646"},{"key":"1468_CR23","doi-asserted-by":"publisher","unstructured":"G. Mazziotti, A. Giustina, Glucocorticoids and the regulation of growth hormone secretion. Nat. Rev. Endocrinol. (2013). \n                        https:\/\/doi.org\/10.1038\/nrendo.2013.5","DOI":"10.1038\/nrendo.2013.5"},{"key":"1468_CR24","doi-asserted-by":"publisher","unstructured":"D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985). \n                        https:\/\/doi.org\/10.1007\/BF00280883","DOI":"10.1007\/BF00280883"},{"key":"1468_CR25","doi-asserted-by":"publisher","unstructured":"E. Meucci, D. Milardi, A. Mordente, G.E. Martorana, E. Giacchi, L. De Marinis, A. Mancini, Total antioxidant capacity in patients with varicoceles. Fertil. Steril. (2003). \n                        https:\/\/doi.org\/10.1016\/S0015-0282(03)00404-7","DOI":"10.1016\/S0015-0282(03)00404-7"},{"key":"1468_CR26","doi-asserted-by":"publisher","unstructured":"G.P. Littarru, L. Tiano, Clinical aspects of coenzyme Q10: an update. Curr. Opin. Clin. Nutr. Metab. Care (2005). \n                        https:\/\/doi.org\/10.1097\/01.mco.0000171123.60665.16","DOI":"10.1097\/01.mco.0000171123.60665.16"},{"key":"1468_CR27","doi-asserted-by":"publisher","unstructured":"H.M. Brown-Borg, A.M. Bode, A. Bartke, Antioxidative mechanisms and plasma growth hormone levels: potential relationship in the aging process. Endocrine (1999). \n                        https:\/\/doi.org\/10.1385\/ENDO:11:1:41","DOI":"10.1385\/ENDO:11:1:41"},{"key":"1468_CR28","doi-asserted-by":"publisher","unstructured":"S.J. Hauck, J.M. Aaron, C. Wright, J.J. Kopchick, A. Bartke, Antioxidant enzymes, free-radical damage, and response to paraquat in liver and kidney of long-living growth hormone receptor\/binding protein gene-disrupted mice. Horm. Metab. Res. (2002). \n                        https:\/\/doi.org\/10.1055\/s-2002-34787","DOI":"10.1055\/s-2002-34787"},{"key":"1468_CR29","doi-asserted-by":"publisher","unstructured":"S. Skhanov, Y. Higashi, S.Y. Shai, C. Blackstock, Z. Galvez, C. Vaughn, J. Titterington, P. Delafontaine, Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects. FEBBS Lett. (2001). \n                        https:\/\/doi.org\/10.1016\/j.febslet.2011.08.029","DOI":"10.1016\/j.febslet.2011.08.029"},{"key":"1468_CR30","doi-asserted-by":"publisher","unstructured":"J. Titterington, S. Skhanov, Y. Higashi, C. Vaughn, C. Bowres, P. Delafontaine, Growth hormone releasing peptide-2 suppressed vascular oxidative stress in ApoE-\/- mice but does not reduce atherosclerosis. Endocrinology (2009). \n                        https:\/\/doi.org\/10.1210\/en.2009-0283","DOI":"10.1210\/en.2009-0283"},{"key":"1468_CR31","doi-asserted-by":"publisher","unstructured":"T. Matsuda, H. Saito, T. Inoue, K. Fukatsu, I. Han, S. Furukawa, S. Ikeda, T. Muto, Growth hormone inhibits apoptosis and up-regulates reactive oxygen intermediates production by human polymorphonuclear neutrophils. J. Parenter. Enter. Nutr. (1998). \n                        https:\/\/doi.org\/10.1177\/0148607198022006368","DOI":"10.1177\/0148607198022006368"},{"key":"1468_CR32","doi-asserted-by":"publisher","unstructured":"A. Sanz, R. Gredilla, R. Pamplona, M. Portero-Otin, E. Vara, J.A.F. Tresguerres, G. Barja, Effect of insulin and growth hormone on rat heart and liver oxidative stress in control and caloric restricted animals. Biogerontology (2005). \n                        https:\/\/doi.org\/10.1007\/s10522-004-7380-0","DOI":"10.1007\/s10522-004-7380-0"},{"key":"1468_CR33","doi-asserted-by":"publisher","unstructured":"F.R.F. Seiva, G.M.X. Ebaid, A.V.B. Castro, K. Okoshi, A. Nascimiento, K.K.H. Rocha, C.R. Padovani, A.C. Cicogna, E.L.B. Novelli, Growth hormone and heart failure: oxidative stress and energetic metabolism in rats. Growth Horm. IGF Res. (2008). \n                        https:\/\/doi.org\/10.1016\/j.ghir.2007.11.002","DOI":"10.1016\/j.ghir.2007.11.002"},{"key":"1468_CR34","doi-asserted-by":"publisher","unstructured":"A. Mohn, D. Marzio, C. Giannini, R. Capanna, M. Marcovecchio, F. Chiarelli, Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy. Clin. Endocrinol. (2005). \n                        https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02378.x","DOI":"10.1111\/j.1365-2265.2005.02378.x"},{"key":"1468_CR35","doi-asserted-by":"publisher","unstructured":"M. Scacchi, E. Valassi, A.I. Pincelli, L.M. Fatti, F.P. Giraldi, P. Ascoli, R. Viarengo, B. Cestaro, F. Cavagnini, R. Cazzola, Increased lipid peroxidation in adult GH-deficient patients: effects of short-term GH administration. J. Endocrinol. Invest. (2006). \n                        https:\/\/doi.org\/10.1007\/BF03349194","DOI":"10.1007\/BF03349194"},{"key":"1468_CR36","doi-asserted-by":"publisher","unstructured":"J.C. Smith, D. Lang, J. McEneny, L.M. Evans, M.F. Scanlon, I. Young, J. Davies, Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency. Clin. Endocrinol. (2002). \n                        https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01493.x","DOI":"10.1046\/j.1365-2265.2002.01493.x"},{"key":"1468_CR37","doi-asserted-by":"publisher","unstructured":"M. Holzenberger, J. Dupont, B. Ducos, P. Leneuve, A. Geoloen, P.C. Even, P. Cervera, Y. Le Bouc, Igf-1 receptors regulates lifespan and resistance to oxidative stress in mice. Nature (2003). \n                        https:\/\/doi.org\/10.1038\/nature01298","DOI":"10.1038\/nature01298"},{"key":"1468_CR38","doi-asserted-by":"publisher","unstructured":"L. Fontana, L. Partridge, V.D. Longo, Extending healthy life span from yeast to humans. Science (2010). \n                        https:\/\/doi.org\/10.1126\/science.1172539","DOI":"10.1126\/science.1172539"},{"key":"1468_CR39","doi-asserted-by":"publisher","unstructured":"Y. Suh, G. Atzmon, M.O. Cho, D. Hwang, B. Liu, D.J. Leahy, N. Barzilai, P. Cohen, Functionally significant insulin growth factor I receptor mutations in centenarians. Proc. Natl. Acad. Sci. USA (2008). \n                        https:\/\/doi.org\/10.1073\/pnas.0705467105","DOI":"10.1073\/pnas.0705467105"},{"key":"1468_CR40","doi-asserted-by":"publisher","unstructured":"J. Guevara-Aguirre, P. Balasubramanian, M. Guevara-Aguirre, M. Wei, F. Madia, C.W. Cheng, D. Hwang, A. Martin-Montalvo, J. Saavedra, S. Ingles, R. de Cabo, P. Cohen, V.D. Longo, Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. (2011). \n                        https:\/\/doi.org\/10.1126\/scitranslmed.3001845","DOI":"10.1126\/scitranslmed.3001845"},{"key":"1468_CR41","doi-asserted-by":"publisher","unstructured":"L. Giovannini, G. Tirabassi, G. Muscogiuri, C. Di Somma, A. Colao, G. Balercia, Impact of adult growth hormone deficiency on metabolic profile and cardiovascular risk. Endocr. J. 62(12), 1037\u20131048 (2015).\u00a0\n                        https:\/\/doi.org\/10.1507\/endocrj.EJ15-0337","DOI":"10.1507\/endocrj.EJ15-0337"},{"key":"1468_CR42","doi-asserted-by":"publisher","unstructured":"E. Bonora, G. Targher, M. Alberiche, R.C. Bonadonna, F. Saggiani, M.B. Zenere, T. Monauni, M. Muggeo, Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000). \n                        https:\/\/doi.org\/10.2337\/diacare.23.1.57","DOI":"10.2337\/diacare.23.1.57"},{"key":"1468_CR43","doi-asserted-by":"publisher","unstructured":"P.A. Sarafidis, A.N. Lasaridis, P.M. Nilsson, M.I. Pikilidou, P.C. Stafilas, A. Kanaki, K. Kazakos, J. Yovos, G.L. Bakris, Validity and reproducibility of HOMA-IR, 1\/HOMA-IR, QUICKI and McAuley\u2019s indices in patients with hypertension and type II diabetes. J. Hum. Hypertens. (2007). \n                        https:\/\/doi.org\/10.1038\/sj.jhh.1002201","DOI":"10.1038\/sj.jhh.1002201"},{"key":"1468_CR44","doi-asserted-by":"publisher","unstructured":"D. Capalbo, A. Esposito, N. Improda, M.G. Wasniewska, R. Di Mase, F. De Luca, D. Bruzzese, M. Salerno, Glucose homeostasis in GHD children during long-term replacement therapy: a case-control study. Endocrine (2017). \n                        https:\/\/doi.org\/10.1007\/s12020-017-1408-0","DOI":"10.1007\/s12020-017-1408-0"},{"key":"1468_CR45","doi-asserted-by":"publisher","unstructured":"A. Galimov, A. Hartung, R. Trepp, A. Mader, M. Fl\u00fcck, A. Linke, M. Bl\u00fcher, E. Christ, J. Kr\u00fctzfeldt, Growth hormone replacement therapy regulates microRNA-29a and targets involved in insulin resistance. J. Mol. Med. (2017). \n                        https:\/\/doi.org\/10.1007\/s00109-015-1322-y","DOI":"10.1007\/s00109-015-1322-y"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1468-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1468-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1468-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T04:23:57Z","timestamp":1522124637000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1468-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,15]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1468-1","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,15]]}}}